Premier Biomedical (BIEI) Stock Statistics & Valuation Metrics

Premier Biomedical has a market cap or net worth of $399.99K. The enterprise value is ―.

Premier Biomedical has 999,980,960 shares outstanding. The number of shares has decreased by -2.65% in one year.

Premier Biomedical’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

The current PE Ratio of Premier Biomedical is -4.89. Premier Biomedical’s PEG ratio is ―.

In the last 12 months, Premier Biomedical had revenue of 0.00 and earned -202.17K in profits. Earnings per share was 0.00.

In the last 12 months, operating cash flow was -170.99K and capital expenditures 0.00, giving a free cash flow of -170.99K billion.

Premier Biomedical pays an annual dividend of ―, resulting in a dividend yield of ―

Premier Biomedical upcoming earnings date is ―, TBA Not Confirmed.

Premier Biomedical as a current ratio of <0.01, with Debt / Equity ratio of -22.64%

In the past 12 months, Premier Biomedical has paid -167.90K in taxes.

Premier Biomedical EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.

Premier Biomedical has $4.21K in cash and marketable securities with $568.34K in debt, giving a net cash position of $564.13K billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Premier Biomedical is ―, which is 11.43% higher than the current price. The consensus rating is ―